CVS Health Chief Executive Officer Karen Lynch has stepped down and will be replaced by David Joyner, who runs the company's pharmacy benefit firm, Caremark.

CVS did not break out separate enrollment figures for fully insured group health plans when it posted its earnings.

CVS Health CEO David Joyner promoted an internal executive, Prem Shah, as company group president and hired from the outside, ...

CVS Health fell short on third-quarter profit, but it posted strong sales and shook up leadership under new CEO David Joyner ...

Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $68.4, with a high ...

RBC Capital analyst Ben Hendrix maintained a Buy rating on CVS Health (CVS – Research Report) yesterday and set a price target of $58.00.

CVS Health announced two key leadership appointments as it continues the push to improve its financial performance. | CVS ...

CVS' health services segment generated $44.13 billion in revenue for the quarter, down nearly 6% compared with the same ...

That appointment is effective immediately. Prem Shah, who joined the company in 2013, will lead CVS Caremark, CVS Pharmacy, and the company’s Health Care Delivery businesses. CVS Health runs one of ...

CVS Caremark, a pharmacy benefits manager; Aetna, a health insurance provider, among many other brands. Read More on CVS: CVS Health NewsMORE Related Stocks Indices Commodities ...

This year has been defined by an unsuccessful fight against elevated medical costs for CVS. The third quarter was no ...

CVS Health Q3 profit disappoints as new CEO restructures leadership to tackle insurance struggles and revive growth ...